---
title: "MeiraGTx Holdings plc schließt exklusive Lizenzvereinbarung mit ZipBio für Gentherapie bei geografischer Atrophie"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274660648.md"
datetime: "2026-02-03T13:03:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274660648.md)
  - [en](https://longbridge.com/en/news/274660648.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274660648.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/274660648.md) | [繁體中文](https://longbridge.com/zh-HK/news/274660648.md)


# MeiraGTx Holdings plc schließt exklusive Lizenzvereinbarung mit ZipBio für Gentherapie bei geografischer Atrophie

MeiraGTx Holdings plc hat eine exklusive Lizenzvereinbarung mit ZipBio abgeschlossen. Das Unternehmen erhält exklusive Rechte an ZipBios Therapien für Geographic Atrophy, die auf den Complement Pathway abzielen. Die Vereinbarung umfasst Vorauszahlungen sowie mögliche Meilenstein- und Lizenzzahlungen. Finanzielle Details wurden nicht bekannt gegeben. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MeiraGTx Holdings plc published the original content used to generate this news brief via PR Newswire (Ref. ID: NY76566) on February 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/en/quote/IBBQ.US.md)
- [MeiraGTx Holdings plc (MGTX.US)](https://longbridge.com/en/quote/MGTX.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md)
- [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md)
- [Zenas BioPharma, Inc. (ZBIO.US)](https://longbridge.com/en/quote/ZBIO.US.md)
- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)

## Related News & Research

- [Zenas BioPharma (ZBIO): Does This $300 Million Raise Clarify or Complicate Its Funding Strategy?](https://longbridge.com/en/news/281283235.md)
- [MeiraGTx Extends Perceptive Notes to May 2027, Plans $25M Redemption; Warrants Repriced to $8](https://longbridge.com/en/news/280630952.md)
- [SeaStar Medical Highlights New Positive QUELIMMUNE Data In Pediatric AKI](https://longbridge.com/en/news/281121555.md)
- [Io Biotech Inc - Files Voluntary Chapter 7 Bankruptcy Petition On March 31, 2026 - SEC Filing](https://longbridge.com/en/news/281187506.md)
- [Precigen Details Papzimeos Commercial Launch, Hub Growth and J-Code Catalyst at H.C. Wainwright Chat](https://longbridge.com/en/news/281233412.md)